Katherine Groff, David Allen, Warren Casey, Amy Clippinger. Increasing the use of animal-free recombinant antibodies. ALTEX. 2020;37(2):309-311. doi:10.14573/altex.2001071
Vanessa Monteil, Hyesoo Kwon, Patricia Prado, et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181(4):905-913.e7. doi:10.1016/j.cell.2020.04.004
Huaqi Tang, Yasmine Abouleila, Longlong Si, et al. Human Organs-on-Chips for Virology. Trends in Microbiology. 2020;28(11):934-946. doi:10.1016/j.tim.2020.06.005
Laura Pellegrini, Anna Albecka, Donna L. Mallery, et al. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell. 2020;27(6):951-961.e5. doi:10.1016/j.stem.2020.10.001
Uwe Marx, Takafumi Akabane, Tommy B. Andersson, et al. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. ALTEX. 2020;37(3):365-394. doi:10.14573/altex.2001241
Jie Zhou, Cun Li, Xiaojuan Liu, et al. Infection of bat and human intestinal organoids by SARS-CoV-2. Nature Medicine. 2020;26(7):1077-1083. doi:10.1038/s41591-020-0912-6
Fjodor A. Yousef Yengej, Jitske Jansen, Maarten B. Rookmaaker, Marianne C. Verhaar, Hans Clevers. Kidney Organoids and Tubuloids. Cells. 2020;9(6):1326. doi:10.3390/cells9061326
Michael Balls, Jarrod Bailey, Robert D. Combes. How viable are alternatives to animal testing in determining the toxicities of therapeutic drugs?. Expert Opinion on Drug Metabolism & Toxicology. 2019;15(12):985-987. doi:10.1080/17425255.2019.1694662
Cathalijn H. C. Leenaars, Carien Kouwenaar, Frans R. Stafleu, et al. Animal to human translation: a systematic scoping review of reported concordance rates. Journal of Translational Medicine. 2019;17(1):223. doi:10.1186/s12967-019-1976-2